Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians-Reference-Cited by-同舟云学术

Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians

Published:2018-11-28 Issue:18 Volume:32 Page:2679-2688
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Maruthamuthu Stalinraja,Rajalingam Raja,Pandian Kalaimani,Madasamy Suresh,Manoharan Mythreyee,Pitchai Leishman,Murugesan Amudhan,Mariakuttikan Jayalakshmi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference50 articles.

1. NK cell recognition;Lanier;Annu Rev Immunol,2005

2. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity;Vilches;Annu Rev Immunol,2002

3. NK cell receptors;Lanier;Annu Rev Immunol,1998

4. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Antip58 antibodies reconstitute lysis of MHCclass I-protected cells in NK clones displaying different specificities;Moretta;J Exp Med,1993

5. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals;Foley;Int Immunol,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection;AIDS;2023-09-11

2. Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging;Pharmaceutics;2023-03-11

3. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer;Immunobiology;2023-03

4. Approaching the asymptote;The Lancet HIV;2023-01

5. Immunological and virological findings in a patient with exceptional post-treatment control: a case report;The Lancet HIV;2023-01